151 COLLAGEN BIOMARKER RESPONSE TO ACUTE JOINT INJURY IN A NON-TERMINAL ANIMAL MODEL OF OSTEOARTHRITIS  by Boyce, M. et al.
S76 Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236
and from this automatically to quantify a bone structure marker strongly
associated with the presence of OA. The advantages of this approach are
the use of low cost MRI equipments and a fully automatic computer-
based framework, which makes the developed marker well suitable for
large longitudinal clinical studies.
150
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Purpose: Osteoarthritis (OA) involves cartilage degradation resulting
from biochemical changes. In this study we perform ex-vivo T1-rho
weighted MRI followed by high resolution magic angle spinning (HRMAS)
NMR spectroscopy at 11.7 T using knee articular cartilage acquired from
OA patients during total knee replacement (TKA) surgery. HRMAS ensures
tissue integrity and allows immuno-histochemistry (IHC) and histology
of the same cartilage samples following spectroscopy. We use immuno-
histochemistry and histology to show that the biochemical changes
measured with HRMAS correlate with the histopathology of cartilage,
and thus validate that HRMAS is a viable and powerful addition to our
capabilities to study early and late OA, and it complements the T1-
rho relaxation map acquired using ex-vivo MRI that depicts regions of
increased cartilage degradation in OA specimens.
Methods: Osteoarthritic samples were excised from OA patients (n = 4,
range = 57–81 years) undergoing TKA during surgery. In case of each
patient lateral and medial femoral condyles were acquired, ﬂash-frozen
in dry ice, then immediately stored at −80C until experiments. The
condyles were mounted and secured on a grid (Fig. 1) after thawing
to obtain T1-rho MRI of the ex-vivo specimens using a 3 Tesla GE
scanner. Semi-automatic segmentation software developed in-house
was used to segment the cartilage overlying the condyles and the
mean+SD of T1rho was determined in each case. 8 cartilage punches
were acquired per patient using a 3mm punch resulting in a total of
n = 24 punches. The samples were then analyzed using HRMAS NMR
spectroscopy using a Carr Purcell Meiboom Gill (CPMG) pulse sequence
to determine the biochemical composition of the samples. Following
HRMAS, histologic (hematoxylin/eosin and Safranin-O/Fast Green) and
immunohistochemical evaluation were performed on the same samples
using antibodies that recognize aggrecan cleavage neoepitopes G1-
NITEGE (reﬂecting activities of ADAMTS) and G1-VDIPEN (reﬂecting
activities of MMPs) as well as those that recognize the collagen-II
cleavage neoepitopes (GPQG).
Fig. 1. OA knee cartilage/bone specimen ﬁxed on a plastic grid for MRI
ex-vivo scan.
Results: Figure 2(A) shows a representative segmented ex-vivo T1-rho
weighted MRI color map of the lateral inferior femoral condyle of an OA
patient. The mean+ SD of T1-rho for the segmented cartilage was (60.4+
18.45) ms. The corresponding HRMAS spectra of the punch sample shown
in 2(A) is indicated in Figure 2(B), with well resolved spectral peaks
including N-acetyl (reﬂecting proteoglycan concentration) and alanine
(reﬂecting collagen concentration). Figure 3 shows the H&E staining,
Safranin-O staining and the immuno-histochemical labeling of anti-
NITEGE of the same punch sample as was used for HRMAS acquisition.
Conclusions: This study is a multi-modality approach to understand the
biochemical changes involved in OA. The use of HRMAS spectroscopy
after performing ex-vivo T1-rho MRI allows the correlation of T1-
rho relaxation with biochemical proﬁles of cartilage as determined
by HRMAS. The fact that cartilage samples remain intact after HRMAS
provides the ability to perform histo-pathological analysis of the same
cartilage samples. Quantitative analysis of T1-rho values, HRMAS spectral
quantiﬁcation and histology/IHC staining grading will be performed with
data collected from this study. This technique provides a validation of
spectroscopy approach and helps establish potential biomarkers of the
cartilage degradation process in OA.
Fig. 2. (A) Representative ex-vivo T1-rho weighted MRI of osteoarthritic
femoral condyle and (B) the corresponding HRMAS spectra of a cartilage
punch (indicated in A) acquired from the same femoral condyle
indicating the resonance arising from the N-acetyl side-chain protons of
proteoglycan and the alanine resonance corresponding to the collagen.
Fig. 3. Histological/immunohistochemical sections of cartilage (the same
punch sample as in Figure 2) stained using (A) H&E, (B) Safranin-O,
(C) anti-NITEGE.
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Purpose: Biomarkers of cartilage metabolism have potential to identify
early stages of osteoarthritis (OA), before clinical evidence is present,
and thus facilitate early diagnosis and therapy. The purpose of this study
was to identify synovial ﬂuid (SF) and serum biomarker changes that
occur after acute joint injury using an equine model of early OA. We
hypothesized that collagen biomarkers would identify early metabolic
changes that occur secondary to acute osteochondral (OC) injury.
Methods: Twenty-two clinically and radiographically normal age- and
sex-matched Quarter Horses were randomly divided into 2 groups:
(1) horses (n =11) that had an OC fragment created arthroscopically
on the dorsomedial aspect of the ﬁrst phalanx in one randomly
selected metacarpophalangeal (MCP) joint and a sham operation in the
contralateral joint at week 0; and (2) unoperated exercise control horses
(n = 11). All horses were exercised on a high-speed treadmill 5 days/week
from week 2 to week 16. Blood was collected from the jugular vein and SF
samples were collected without lavage from both MCP joints of all horses
at baseline (week 0), week 2, 8, and 16. Commercially available collagen
degradation (CTXII [IDS/Nordic], C2C, C12C [IBEX]) and synthesis (CPII
[IBEX]) ELISA assays were used to analyze SF and serum samples. All
assays were previously validated for equine use. Data was assessed for
normality and outliers were removed from further analyses. A repeated
measures ANOVA with a Tukey’s test for multiple comparisons was used
for all analyses. P≤ 0.05 was considered signiﬁcant. All procedures were
approved by institutional animal care and use committees.
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Fig. 1. MCP synovial ﬂuid and serum biomarker results over 16 weeks.
A standardized scale has been used to show relative relationships.
Signiﬁcant differences are not shown in the ﬁgure because of the
standardized scale. Refer to the text for signiﬁcant differences.
Results: In SF, all collagen biomarkers signiﬁcantly increased from
baseline at weeks 2, 8, and 16 (P < 0.0001). In addition, SF from OC injured
joints had signiﬁcantly higher concentrations of all collagen biomarkers
when compared to SF from control and sham joints (P < 0.05). The only
exception was at week 8 with CPII, when OC injured and sham joints
were not signiﬁcantly different. Figure 1 compares all of the collagen
biomarkers on a standardized scale to show the relative response over
time. CPII and C2C concentrations peaked at week 2, C12C at week 8,
and CTX II at week 16. The only signiﬁcant change in serum biomarkers
was a decreased C12C concentration at week 2 in both OC injured and
control horses (P < 0.05). There were no signiﬁcant differences in serum
concentrations between OC injured horses and controls.
Conclusions: This study demonstrated that in an acute joint injury model
of OA, SF is more sensitive than serum in determining changes that occur
in collagen biomarkers. The relationships between multiple biomarkers
over time helps to more accurately delineate the metabolic changes
that occur after acute joint injury. We used 3 collagen degradation
biomarkers to further elucidate changes in collagen metabolism after
injury. C12C and C2C were elevated throughout most of the study period,
but started to decline with chronicity. Since these neoepitopes result
from collagenase cleavage, this may suggest that most of the collagenase
damage to collagen occurs within the ﬁrst 2 to 3 months of injury.
Conversely, CTX II continued to increase throughout the study, suggesting
that telopeptide breakdown is mediated by other biochemical pathways
such as cathespin K, or secondary to protease cleavage. Collagen synthesis
increased by week 2 after injury, as indicated by a peak in CPII
concentration. However, CPII came back toward baseline concentrations
by week 8 while degradation (CTX II) concurrently increased. This may
suggest that in spite of an early anabolic response in the injured joint,
the joint becomes more catabolic between weeks 2 and 8 after injury.
Analysis of synovial ﬂuid in an animal model of acute injury may have
future application deﬁning the onset and progression of OA and allowing
the evaluation of future therapies.
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Purpose: Total knee arthroplasty (TKA) is usually recommended for those
with the most severe knee osteoarthritis (OA), as it has been established
as a highly successful procedure for treating patients with severe knee
OA. However, the decision whether to have a joint replacement or not
is ambiguous. For the selection of patients receiving TKA, age, general
health status, willingness to consider joint replacement, and severity
of symptoms including in response to other treatment modalities are
generally taken into account in addition to a radiographic severity of
OA. The decision whether to have a TKA or not is a judgment call that
has to be made by the physician and patient working together. For the
physician, objective factors which can represent the past results of the
patients who had already received TKA, if available, would be helpful to
discuss with the patients for the decision. However, the characteristics
of patients who will actually receive TKA are poorly understood.
The gold standard for assessing joint damage is still the plain radiograph
and this method only provides a historical view of the skeletal damage
that has already occurred. In contrast, biomarkers are candidates to
predict an event that would occur in OA. Monitoring serum levels of
hyarulonic acid (sHA) is considered to be a potential biomarker in knee
OA. It is reported that sHA is well associated with the symptom of OA
patients, which is an important factor for the indication of TKA. These
results are consistent with the speculations that sHA may be useful as a
burden of disease marker in BIPEDS classiﬁcations for knee OA patients.
The purpose of this study was to investigate whether sHA can be available
as a predictor of TKA for Japanese patients with radiographic severe
knee OA.
Methods: This case-control study protocol was approved by the
institutional review board of our university. One hundred twenty-
one painful knee OA patients with K/L grade 4 were enrolled in this
study. Serum samples were obtained from all subjects on the day that
radiographs taken. A HA binding protein based latex agglutination assay
that employed an ELISA format was used to measure the level of HA.
Age, gender and body mass index (BMI) adjusted one way analysis of
variance (ANOVA) was used for parametric comparisons. The AUC, which
is analogous to the area under the the receiver operating characteristic
(ROC) curve, was estimated for the discriminative value of prediction
models. Odds ratios (ORs) were calculated to evaluate the sHA cut-off
score for receiving TKA. A p-value of less than 0.05 was considered to be
statistically signiﬁcant.
Results: In this study, patients were followed for 6 months on average.
While 36 of 121 patients were received TKA (OP group), remaining 85 of
121 patients were not (NOOP group). No gender distribution (86.8% was
female in total), age (72.4 y on average) and BMI (25.3 kg/m2) differences
were observed between OP group and NOOP group, respectively. As the
sHA levels of the patients did not show normal distribution, the sHA
levels were logarithmically transformed (ln-sHA), thus resulting in a
normal distribution. The age, gender and BMI adjusted ln-sHA levels at
baseline of OP group were signiﬁcantly increased in comparison to those
of NOOP group (p < 0.05). The AUC in ROC curve of sHA was 0.64 (95%
CIs; 0.53, 0.74). The cut-off of sHA level calculated by ROC curve was
found at 55.0 ng/ml and the ORs at 55.0 ng/ml of sHA level for receiving
TKA was 2.9 (95% CIs; 1.1, 7.4).
Conclusions: These results suggest the potential of sHA as not only a
burden of disease marker but also a prognosis marker that can be useful
for predicting the patients who will receive TKA among severe knee OA
patients. In conclusion, sHA could be a one of the objective factors for the
prediction of receiving TKA among the patients with severe knee OA.
